Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Pharmaceutics|May 28, 2022
<sup>123</sup>I-BMIPP, a Radiopharmaceutical for Myocardial Fatty Acid Metabolism Scintigraphy, Could Be Utilized in Bacterial Infection ImagingYuka Muranaka, Asuka Mizutani, Masato Kobayashi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2022
Estimation of post-therapeutic liver reserve capacity using <sup>99m</sup>Tc-GSA scintigraphy prior to carbon-ion radiotherapy for liver tumorsKana Yamazaki, Ryuichi Nishii, Yoichi Mizutani, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 20, 2009
FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinomaTatsuya Higashi, Etsuro Hatano, Iwao Ikai, et al.
Scientific Reports|August 11, 2022
[S-methyl-<sup>11</sup>C]-L-methionine positron emission tomography/computed tomography imaging parameters to evaluate early response for esophageal cancer with neoadjuvant carbon ion radiotherapyKazuo Narushima, Ryuichi Nishii, Shinichi Okazumi, et al.
Molecular Imaging and Biology|March 26, 2011
Pharmacokinetics, metabolism, biodistribution, radiation dosimetry, and toxicology of (18)F-fluoroacetate ((18)F-FACE) in non-human primatesRyuichi Nishii, William Tong, Richard Wendt, et al.
Annals of Nuclear Medicine|February 2, 2018
<sup>18</sup>F-FPYBF-2, a new F-18-labelled amyloid imaging PET tracer: first experience in 61 volunteers and 55 patients with dementiaTatsuya Higashi, Ryuichi Nishii, Shinya Kagawa, et al.
Plos One|June 7, 2013
Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcomeYukie Yoshii, Takako Furukawa, Nobuyuki Oyama, et al.
Annals of Nuclear Medicine|January 2, 2021
Clinical value of PET/CT with carbon-11 4DST in the evaluation of malignant and benign lung tumorsRyuichi Nishii, Tsuneo Saga, Hitomi Sudo, et al.
Frontiers in Pharmacology|July 4, 2024
Development of radioiodine-labeled mequitazine for evaluation of hepatic CYP2D activityAsuka Mizutani, Masato Kobayashi, Kodai Nishi, et al.
Annals of Nuclear Medicine|March 7, 2014
Assessment of [(18)F]-fluoroacetate PET/CT as a tumor-imaging modality: preclinical study in healthy volunteers and clinical evaluation in patients with liver tumorKenji Takemoto, Etsuro Hatano, Ryuichi Nishii, et al.
Pageof 13